Accurate methods of detecting common bile duct and pancreatic disease in patients are important to both surgeons and endoscopists for planning an effective interventional strategy and therefore a need for less invasive, safe and highly sensitive diagnostic procedure.
INTRODUCTION
Accurate methods of detecting common bile duct and pancreatic disease in patients are important to both surgeons and endoscopists for planning an effective interventional strategy and therefore a need for less invasive, safe and highly sensitive diagnostic procedure. 1 Various invasive and non-invasive diagnostic techniques have been employed to achieve this aim. 2 Non-invasive techniques such as ultrasound and CT scan (abdomen and pelvis) are widely used in preliminary investigations of pancreaticobiliary disease, though easily available and less expensive, have limitations in term of sensitivity such as low sensitivity of USG for detecting common duct calculi, which means that the diagnosis of several common conditions like tumours, calculi, sclerosing cholangitis and chronic pancreatitis may require invasive procedure. 2 Invasive procedures like ERCP, though considered gold standard for diagnosis of pancreaticobiliary disease, requires highly skilled team of supporting doctors, for cannulation of pancreatic and common bile duct, as also the use of sedation and ionizing radiations. 2 MR Cholangio Pancreatography (MRCP) is evolving as an effective non invasive imaging technique for examining patients with suspected pancreatic or biliary diseases.
The projectional images rendered by this technique resemble those provided by direct cholangiography or pancreatography obtained via invasive procedures such as endoscopic retrograde cholangiopancreatography or percutaneous transhepatic cholangiography. The purpose of this study is to illustrate the findings of MRCP in various abnormalities affecting the pancreaticobiliary diseases. 3 MRCP was first performed in 1991 by a scientist named Wallen. Since its first clinical introduction, MRCP has proved to be a reliable technique in the evaluation of biliary and pancreatic duct obstruction. In early phases of its clinical application, it was considered a second level examination in the diagnostic workup of obstructive pathologies, following percutaneous transhepatic cholangiography and endoscopic retrograde cholangiopancreatography which were considered first level examinations.
Since decades, this imaging technique has significantly increased its diagnostic role in diagnosis of obstructive biliary pathologies. Now a days MRCP is widely used as a primary noninvasive imaging modality in the diagnosis of obstructive biliary pathologies. It plays a primary role in its workup and therapeutic operative planning. 4 It makes use of heavily T2 weighted pulse sequences, thus exploiting the inherent differences in the T2 weighted contrast between stationary fluid filed structures in the abdomen (which have long T2 relaxation time) and adjacent soft tissue (which has a much shorter T2 relaxation time). 5, 6 Heavily T2-weighted fat suppressed sequences are used to produce images, in which static fluid is hyperintense, and background signal is suppressed. These images are suitable for postprocessing into projection images that resemble direct cholangiogram produced by ERCP or percutaneous transhepatic cholangiopancreatography. 7 MRCP is the investigation of choice for the upper biliary tract pathologies as ERCP is not very helpful in those circumstances due to technical shortcomings. But ERCP is the gold standard of investigation as far as lower pancreatobiliary pathologies are concerned. In this study, we are going to study the role of MRCP in diagnosing as well as in planning the treatment modality of the lower pancreatico biliary diseases.
METHODS
This is a prospective study conducted in Dr DY Patil Medical College, Hospital and Research Centre from July 2015 to September 2017. 60 patients were enrolled in the study after obtaining clearance from Institutional Ethics Committee and informed written consent from each patient.
Inclusion criteria included age group of 18-80 years of any sex suffering from common bile duct and pancreatic pathologies, while patients having congenital abnormalities or could not undergo MRCP due to metallic implants or claustrophobia were excluded. enrolled patients underwent MRCP (HASTE coronal and axial, T1 weighted axial, MRCP using heavily T2 weighted sequences) in Siemens 1.5 Tesla Magnetom Avanto.
Following diagnosis of common bile duct or pancreatic pathology after blood investigations (hemogram, complete blood count, liver and renal function tests, coagulation and lipid profile, serum pancreatic enzymes) and ultrasonography of abdomen and pelvis, MRCP was done. On basis of MRCP, patients were subjected to either endoscopic/surgical procedure or medical treatment and histopathological examination was done.
RESULTS
Our study was a hospital based prospective study of 60 patients with clinical, biochemical or radiological suspicion of hepatobiliary pathologies.
Patients were of age group 25-70 years with a mean age of 46.33 years. Out of 60 patients, 35 patients were females (58.3%). 13 out of 60 patients had a surgical history in the past either open or laproscopic (21.67%). Alcoholic history was present in 5 out of 60 patients (8.3%).
Out of 60 patients, 13 patients had icterus (21.67%). Elevated levels of direct bilirubin were present in 14 out of 60 patients (23.3%). Increased levels of alkaline phosphatase enzyme were present in 14 out of 60 patients (23.3%).
1 patient out of 60 has sclerosing cholangitis (1.7%). Gall bladder perforation was found in 1 out of 60 patients (1.7%). Extraluminal common bile duct compression was found in 1 out of 60 patients (1.7%). Iatrogenic common bile duct injury was found in 1 out of 60 patients (1.7%). Postoperative follow up was done in 1 out of 60 patients (1.7%). 
DISCUSSION
Features of obstructive jaundice were present in 14 out of 60 patients (23.3%). The most common presenting complaints of the subjects in our study was jaundice (92%) which is consistent with the study by Verma et al. 8 Out of 60 patients, 24 patients had cholelithiasis (40.0%). Choledocholithiasis was present among 10 out of 60 patients (16.7%). Several studies have been conducted which have reported a significantly high accuracy in detecting the biliary dilatation and obstruction level.
Regan et al showed dilatation of biliary tract in 100% cases and diagnosed the obstruction level in 87% cases. 9 Magnuson et al diagnosed the level of obstruction in 24 cases and cause of obstruction in 21 patients out the 25 patients with obstruction due to malignancy. Of 48 patients with a benign iteology, they were able to diagnose 45. 10 Georgopoulos et al diagnosed the obstruction level accurately in 13 (87%) of 15 patients with malignant obstruction. 11 Adamek et al showed that MRCP can identify the biliary obstruction level with a high sensitivity of 90% and a specificity about 100%. 12 Common bile duct stricture was present in 7 out of 60 patients (11.7%). All the strictures were benign in nature. In a study by Obaidi et al the sensitivity was 100%, specificity 98.5%, negative predictive value 100%, positive predictive value 91.6%, and diagnostic accuracy 98.7% for benign strictures. 13 The criteria for differentiation of benign and malignant strictures included
• irregular margin • biliary radicles asymmetrically dilated • abrupt or graded tapering of stricture • presence or absence of a mass • length of the structure.
Malignant strictures are long as they have an infiltrative growth fashion, which spreads intramurally beneath the epithelial lining. They are irregular in nature with an asymmetrically dilated biliary duct because of the nature of infiltration of the bile duct by the tumor. Presence of a mass, stricture of long length (3 cm vs. 1.2 cm), and an irregular margin and asymmetrically dilated bile ducts pointed towards the diagnosis of a malignant stricture. Park et al found out that stricture length (3 cm vs. 1.3 cm) with capricious margin and asymmetric narrowing of bile ducts were suggestive of malignant etiology. 14 Bain et al found out that lengthy stricture (3 cm vs. 0.8 cm) and the dilated intrahepatic duct (93% vs. 36%) were suggestive of malignant etiology. 15 6 out of 60 patients had chronic pancreatitis (10%). 4 out of 60 patients had pseudocyst of pancreas (6.7%). Choledochal cyst was present in 2 cases out of 60 (3.3%). Cholangiocarcinoma was found in 2 out of 60 patients (3.3%). The sensitivity and specificity of MRCP was 81% and 100% compared to that of ERCP which was 93% and 94% for the detection of malignancy Bile Duct. Manfriedi et al found at the level and extent of the bile duct involvement with cholangiocarcinoma using the Bismuth-corlette classification was accurately depicted on MRCP in 84% (10 of 12) of their patients. MRCP can accurately depict the presence and level of obstruction and has been shown to be more effective than ERCP in delineating anatomic extent of the cancerous infilteration. 16 According to current studies, MRCP has the aptitude to replace diagnostic ERCP and avoid complications related to it. The accuracy of MRCP has been documented in various studies, with sensitivity being 85-97%, specificity 75-98%, positive predictive values 83-89%, and negative predictive values 82-98%. 3, 17, 18 MRCP is a non-invasive imaging modality that has alpine sensitivity and specificity for the detection of pancreatobiliary pathologies. It is relatively safe, well tolerated by the patients, and has less contraindications and negligible morbidity or mortality. Dalton SJ et al compared MRCP with ERCP and their outcome have confirmed that MRCP has an accuracy of about 95%; and especially negative predictive value reaches 100%. 19 Topal B et al compared MRCP findings with that of ERCP have concluded that dependence upon MRCP might have cut down the requirement for ERCP and sphincterotomy by up to 75%. 20 For these reasons, MRCP has been included in the investigation of pancreatobiliary pathologies. Barring few claustrophobic patients, it has proved highly acceptable, and has been cardinal in reducing the rate of 'negative' ERCPs. None of the patient whose MRCP suggested a clear CBD returned with symptomatic CBD stones during the duration of our study, thus assuring the tall negative predictive value for MRCP.
CONCLUSION
MRCP is the modality of choice for optimal characterization of the causative lesions in most of the cases of pancreatobiliary pathogies. It has sensitivity and specificity of 91-94% and 93-100% in detecting common bile duct pathologies. It has a very high accuracy in detecting pancreatic duct pathologies. It can detect a pancreatic duct calculus as small as 2mm. It helps in determining the modality of treatment either surgical or endoscopic and helps in reducing the invasive intervention done in the patient. It has significantly reduced the number of negative ERCPs in the patients. It provides the benefit of secondary opinion wherever necessary. On the contrary, ERCP is a singular-vision procedure. It proves to be a suitable mode of investigation when the patient is unfit for an invasive ERCP. A female preponderance for pancreatobiliary pathologies was noted in our study. It also has some drawbacks. MRCP is a solely diagnostic procedure with no therapeutic potential. There is delay in the treatment offered to the patient and ERCP can diagnose and treat the condition in the same setting. MRCP has been entirely futile in following cases.
